Quest Diagnostics (DGX) Declares $0.62 Quarterly Dividend; 1.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Quest Diagnostics (DGX) Appoints Tracey C. Doi to its Board
August 17, 2021 6:45 AM EDTQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director. Including Ms. Doi, the company's Board has 10 members.
Ms. Doi is the Chief Financial Officer of Toyota Motor North America, where she is responsible for accounting, finance, tax... More
Quest Diagnostics (DGX) PT Raised to $150 at Credit Suisse
August 13, 2021 5:45 AM EDTCredit Suisse analyst A.J. Rice raised the price target on Quest Diagnostics (NYSE: DGX) to $150.00 (from $135.00) while maintaining a Neutral rating.... More
